1. metametabolo Metabolomics Market Global Opportunity Analysis and Industry Forecast, 2017-2023

2. According to a new report published by Allied Market Research, titled, Metabolomics Market by Product & Service, Application, and Indication: Global Opportunity Analysis and Industry Forecast, 2017-2023," the global metabolomics market accounted for $1,379 million in 2016, and is estimated to reach $3,301 million by 2023, registering a CAGR of 13.2% from 2017 to 2023. North America was the highest contributor to the global metabolomics market in 2016; while, Asia-Pacific is anticipated to witness the highest growth rate throughout the forecast period.

3. Metabolomics uses various analytical methods, such as spectroscopy, chromatography, and • multivariate analysis, for the identification & quantification of various metabolites. • The analytical methods facilitate the classification of various known & unknown metabolites • The comprehensive nature of metabolites enables its application in diverse medical fields; • thereby, facilitating the development of new therapeutic procedures and diagnostics tests • The global metabolomics market is expected to grow at a lucrative rate during the forecast period due to increased adoption of metabolomics in precision medicine and surge in R&D investments. Moreover, technological advancements in auxiliary medical devices used for metabolomics analysis and growth in demand for the development of quality medications are expected to fuel the metabolomics market. However, high cost of medical devices and lack of effective data management for metabolomic profiling hamper the market growth.

4. Key Findings of the Metabolomics Market: • The drug discovery segment is estimated to grow at the highest rate during the forecast period. • The biomarker discovery segment generated the highest revenue in 2016, and is expected to continue its dominance in the near future. • North America dominated the global market in 2016. • China is expected to grow at the highest CAGR in the Asia-Pacific region.

5. Key players in the market : • Agilent Technologies Inc. • Danaher Corporation • Biocrates Life Sciences AG • Bruker Corporation • Leco Corporation • Metabolon Inc. • Human Metabolome Technologies Inc. • Bio-Rad Laboratories Inc. • Shimadzu Corporation • Waters Corporation • Thermo Fisher Scientific Inc.

6. Metabolomics Market by Product & Service (Metabolomics Instruments and Metabolomics Bioinformatics Tools and Services), Application (Biomarker Discovery, Drug Discovery, Toxicology Testing, Nutrigenomics, Functional Genomics, Personalized Medicine, and Others), Indication (Cancer, Cardiovascular Disorders, Neurological Disorders, Inborn Errors of Metabolism, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023 View Report